In vitro evaluation of novel mucoadhesive buccal tablet of oxytocin prepared with diospyros peregrina fruits mucilages

Yakugaku Zasshi

Volumn 128, Issue 4, 2008, Pages 603-609

  Metia, Pulak Kumar ^a   Bandyopadhyay, Amal Kumar ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Buccal permeation; Mucoadhesive; Oxytocin; Permeation enhancer

Indexed keywords

ACETONITRILE; BUFFER; OXYTOCIN; PENETRATION ENHANCING AGENT; PHOSPHATE; POTASSIUM DIHYDROGEN ORTHOPHOSPHATE; POTASSIUM DIHYDROGEN PHOSPHATE; SODIUM THIOGLYCOLLATE; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DRUG PENETRATION; DRUG RELEASE; FLOW RATE; IN VITRO STUDY; MUCILAGE; NONHUMAN; PERSIMMON; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SHEAR STRENGTH; TABLET FORMULATION; TEMPERATURE; TENSILE STRENGTH;

ADHESIVENESS; ADMINISTRATION, BUCCAL; ANIMALS; CATTLE; CELL MEMBRANE PERMEABILITY; DIOSPYROS; DRUG DELIVERY SYSTEMS; FRUIT; MOUTH MUCOSA; OXYTOCIN; PLANT EXTRACTS; TABLETS;

EID: 41849143404     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.603     Document Type: Article

References (24)

1. Siddiqui O., Chien Y. W., Crit. Rev. Ther. Drug Carr. Syst., 3, 195-208 (1987).
2. Lee V. H. L., Crit. Rev. Ther. Drug Carr. Syst., 5, 69-97 (1988).
3. Silvia R., Giuseppina S., Carla C., Am. J. Drug Del., 3, 215-225 (2005).
4. Cunningham F. G., Gant N. F., Leveno K. J., Gilstrap L. C., Hauth J. C., Wenstrom K. D., "Williams Obstetrics, 21st ed.," McGraw Hill, New York, 2001, pp. 474-478.
5. Murakami T., Susaki Y., Yamajo R., Yata N., Chem. Pharm. Bull., 32, 1948-1955 (1984).
6. Yamamoto A., Luo A. M., Dodda-Kashi S., Lee V. H. L., J. Pharmacol. Exp. Ther., 249, 249-255 (1989).
7. Hogan D. T. O., Illum L., Crit. Rev. Ther. Drug Carr. Syst., 7, 35-97 (1990).
8. Su K. S. E., "In Peptide and Protein Drug Delivery," ed. by Lee, V. H. L., Marcel Dekker, New York, 1991, pp. 595-631.
9. Okada H., "In Peptide and Protein Drug Delivery," ed. by Lee, V. H. L., Marcel Dekker, New York, 1991, pp. 633-666.
10. Wearly L. L., Crit. Rev. Ther. Drug Carr. Syst., 8, 331-394 (1991).
11. Hirai S., Yashiki T., Mim H., Int. J. Pharm., 9, 173-184 (1981).
12. Harris A. S., "In Delivery Systems for Peptide Drugs," eds. by Davis, S.S., Illum, L., Tomlinson, E., Plenum Press, New York, 1986, pp. 191-210.
13. deVries M. E., Bodde H. E., Crit. Rev. Ther. Drug Carr. Syst., 8, 271-303 (1991).
14. Senel S., Capan Y., Sargon M. F., Giray C. B., Hincal A. A., Int. J. Pharm., 170, 239-245 (1998).
15. Weatherell J. A., Robinson C., Rathbone M. J., "Oral Mucosal Drug Delivery," ed. by Rathbone, M. J., Marcel Dekker, New york, 1996, pp. 157-191.
16. Senel S., Hincal A. A., J. Controlled Release, 72, 133-144 (2001).
17. Rao Y. M., Vani G., Ind. Drugs, 35, 558-565 (1998).
18. Park H., Robinson J. R., Pharm. Res., 4, 457-464 (1987).
19. Vermani K., Garg S., Zaneveld L. J. D., Drug Dev. Ind. Pharm., 28, 1133-1146 (2002).
20. Park H., Robinson J. R., Int. J. Pharm., 19, 107-127 (1984).
21. Lee J. W., Park J. H., Robinson J. R., J. Pharm. Sci., 89, 850-866 (2000).
22. Smart J. D., Int. J. Pharm., 73, 69-74 (1991).
23. Frantz S. W., "Instrumentation and Methodology for in vitro Skin Diffusion Cells in Methodology for Skin Absorption," In: Methods for Skin Absorption., eds. by Kemppainen B. W., Reifenrath W. G., CRC Press, Florida, 1990, pp. 35-59.
24. Parodi B., Russo E., Gatti P., Cafaggi S., Bignardi G., Drug Dev. Ind. Pharm., 25, 289-295 (1999).